c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  1998-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V91.4.1101PMID 9454740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Requirements for ! 4 Integrins during Fetal and Adult Hematopoiesis

  2008cited by this paper
• C-kit receptor (CD0117) expression in acute leukemia

  2004cited by this paper
• Modulation of Megakaryocytopoiesis by Thrombopoietin : The c-Mpl Ligand

  2000cited by this paper
• Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

  1997cited by this paper
• FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction.

  1997cited by this paper
• Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivo.

  1997cited by this paper
• In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand.

  1997cited by this paper
• Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.

  1997cited by this paper
• Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.

  1997cited by this paper
• Interactions between c-kit and stem cell factor are not required for B-cell development in vivo.

  1997cited by this paper
• Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia

  1997cited by this paper
• Pluripotent hemopoietic stem cells are c-Kit[low]

  1997cited by this paper
• Flt3 ligand induces tumor regression and antitumor immune responses in vivo

  1997cited by this paper
• Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.

  1997cited by this paper
• Differential effects of Flk-2/Flt-3 ligand and stem cell factor on murine thymic progenitor cells.

  1997cited by this paper
• Stem cell factor and hematopoiesis.

  1997cited by this paper
• Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trial.

  1997cited by this paper
• Pluripotent hemopoietic stem cells are c-kit

  1997cited by this paper
• Kit Receptor Dimerization Is Driven by Bivalent Binding of Stem Cell Factor*

  1997cited by this paper
• Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood.

  1997cited by this paper
• Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.

  1997cited by this paper
• The Majority of Stem Cell Factor Exists as Monomer under Physiological Conditions

  1997cited by this paper
• Isolation and characterization of primitive hematopoietic progenitors of murine fetal liver.

  1996cited by this paper
• Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.

  1996cited by this paper
• Purification of repopulating hemopoietic cells based on binding of biotinylated Kit ligand.

  1996cited by this paper
• Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.

  1996cited by this paper
• Hematologic effects of flt3 ligand in vivo in mice.

  1996cited by this paper
• Differential requirements for alpha4 integrins during fetal and adult hematopoiesis.

  1996cited by this paper
• FLT3/FLK‐2 (STK‐1) Ligand Does Not Stimulate Human Megakaryopoiesis In Vitro

  1996cited by this paper
• Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

  1996cited by this paper
• Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.

  1996cited by this paper
• Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo.

  1996cited by this paper
• STEM CELL FACTOR AND THE REGULATION OF DENDRITIC CELL PRODUCTION FROM CD34+ PROGENITORS IN BONE MARROW AND CORD BLOOD

  1996cited by this paper
• The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells.

  1996cited by this paper
• flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors.

  1996cited by this paper
• Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.

  1996cited by this paper
• Dendritic cells: from ontogenetic orphans to myelomonocytic descendants.

  1996cited by this paper
• Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase (*)

  1996cited by this paper
• Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.

  1996cited by this paper
• Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells.

  1996cited by this paper
• Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins

  1996cited by this paper
• Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.

  1996cited by this paper
• Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.

  1996cited by this paper
• TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro.

  1996cited by this paper
• Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand.

  1996cited by this paper
• Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.

  1996cited by this paper
• Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines.

  1996cited by this paper
• Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell

  1996cited by this paper
• Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin‐11 and interleukin‐7

  1996cited by this paper
• Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.

  1996cited by this paper
• Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors.

  1996cited by this paper
• Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.

  1996cited by this paper
• Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice.

  1996cited by this paper
• Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3.

  1996cited by this paper
• Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells.

  1996cited by this paper
• Stem cell factor serum levels may not be clinically relevant.

  1996cited by this paper
• Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo.

  1996cited by this paper
• Regulation of colony forming cell generation by flt‐3 ligand

  1996cited by this paper
• The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro.

  1996cited by this paper
• Cloning and characterization of cDNAs encoding two forms of avian stem cell factor.

  1996cited by this paper
• Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells

  1996cited by this paper
• Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.

  1996cited by this paper
• Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: biologic similarity with membrane-bound form of Steel factor rather than its soluble form.

  1996cited by this paper
• The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.

  1996cited by this paper
• Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.

  1996cited by this paper
• The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

  1996cited by this paper
• Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow.

  1996cited by this paper
• Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.

  1996cited by this paper
• Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin

  1996cited by this paper
• Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

  1996cited by this paper
• Generation of human T lymphocytes from bone marrow CD34+ cells in vitro

  1996cited by this paper
• Dendritic Cell Development in Culture from Thymic Precursor Cells in the Absence of Granulocyte/Macrophage Colony-stimulating Factor

  1996cited by this paper
• Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias.

  1996cited by this paper
• Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells.

  1996cited by this paper
• Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.

  1996cited by this paper
• Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.

  1996cited by this paper
• Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia.

  1996cited by this paper
• Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta.

  1996cited by this paper
• Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.

  1996cited by this paper
• Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen.

  1996cited by this paper
• Regulatory Roles of the Ligand for Flk2/Flt3 Tyrosine Kinase Receptor on Human Hematopoiesis

  1996cited by this paper
• Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy

  1996cited by this paper
• Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

  1996cited by this paper
• Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.

  1996cited by this paper
• Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.

  1996cited by this paper
• Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody.

  1996cited by this paper
• Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.

  1996cited by this paper
• Flt3 Ligand prolongs survival of CD34+++ human umbilical cord blood myeloid progenitors in serum-depleted culture medium

  1996cited by this paper
• Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity.

  1996cited by this paper
• Biological and clinical advances in stem cell expansion.

  1996cited by this paper
• Retroviral transduction of human progenitor cells: use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro.

  1996cited by this paper
• Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

  1996cited by this paper
• The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.

  1996cited by this paper
• FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells.

  1996cited by this paper
• Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells.

  1996cited by this paper
• flt-3 Ligand Is More Potent Than c-kit Ligand for the Synergistic Stimulation of Ex Vivo Hematopoietic Cell Expansion

  1996cited by this paper
• Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor.

  1996cited by this paper
• CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells.

  1996cited by this paper
• Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics.

  1996cited by this paper
• Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.

  1996cited by this paper

• Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and meningioma.

  2025cites this paper
• FL/FLT3 signaling enhances mechanical pain hypersensitivity through Interleukin-1 beta (IL-1β) in male mice

  2025cites this paper
• The use of autologous platelet-rich plasma in embryo culture to obtain high-quality embryos

  2025influential citation
• c‐KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions

  2025cites this paper
• Directed Differentiation of Natural Killer Cells from Human Induced Pluripotent Stem Cells: From Developmental Cues to In vitro Production

  2025cites this paper
• High FLT3 expression increases immune‐cell infiltration in the tumor microenvironment and correlates with prolonged disease‐free survival in patients with non‐small cell lung cancer

  2024cites this paper
• Blood pharming: exploring the progress and hurdles in producing in-vitro red blood cells for therapeutic applications

  2024cites this paper
• Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges.

  2024cites this paper
• Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques

  2024cites this paper
• Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors

  2024cites this paper
• Precision medicine in AML: overcoming resistance

  2024cites this paper
• Retrospective Safety Evaluation of Combined Chlorambucil and Toceranib for the Treatment of Different Solid Tumours in Dogs

  2024cites this paper
• Human and mouse early B cell development: so similar but so different.

  2023cites this paper
• Systemic mastocytosis: 2023 update on diagnosis and management in adults

  2023cites this paper
• Generation of Red Blood Cells from Human Pluripotent Stem Cells—An Update

  2023cites this paper
• Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect—A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial

  2023cites this paper
• Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor

  2023cites this paper
• FLT3 Inhibitors as Maintenance Therapy after Allogeneic Stem-Cell Transplantation

  2022cites this paper
• [GATA2 gene mutations: 3 cases].

  2022cites this paper
• DNA damage accumulation and repair defects in FLT3‐ITD acute myeloid leukemia: Implications for clonal evolution and disease progression

  2022cites this paper
• Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis

  2022cites this paper
• The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?

  2022cites this paper
• Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death

  2021cites this paper
• Protein Kinase Inhibitors - Selectivity or Toxicity?

  2021cites this paper
• Single-nucleotide polymorphisms in FLT3, NLRP5, and TGIF1 are associated with litter size in Small-tailed Han sheep

  2021cites this paper
• Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations.

  2021cites this paper
• Secondary AML

  2021cites this paper
• Cytomegalovirus subverts macrophage identity.

  2021cites this paper
• Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date

  2020cites this paper
• CMAR_A_196568 151..163

  2020cites this paper
• An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report

  2020cites this paper
• Gilteritinib: potent targeting of FLT3 mutations in AML.

  2020cites this paper
• DRUG INFORMATIONOF GILTERITINIB AND ITS EFFICACY IN REFRACTORY FLT3- MUTATED AML

  2020cites this paper
• Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia

  2020cites this paper
• Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

  2020cites this paper
• The Posterior Signaling Center Is an Important Microenvironment for Homeostasis of the Drosophila Lymph Gland

  2020cites this paper
• Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy

  2020cites this paper
• Orthopaedic Surgery Elicits a Systemic Anti-Inflammatory Signature

  2020cites this paper
• Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

  2019cites this paper
• Fine-Tuning Cytokine Signals.

  2019cites this paper
• C-kit mutacija u akutnoj mijeloičnoj leukemiji s preuredbom gena grupe CBF

  2019cites this paper
• C-kit-derived CD11b+ cells are critical for cardiac allograft prolongation by autologous C-kit+ progenitor cells.

  2019cites this paper
• Ex vivo dendritic cell generation-A critical comparison of current approaches.

  2019cites this paper
• On the Way to Become a Natural Killer Cell

  2019cites this paper
• Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome

  2019cites this paper
• FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications.

  2019influential citation
• Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.

  2019cites this paper
• Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

  2019cites this paper
• Overcoming the Protective Effect of the Bone Marrow Microenvironment by Dual FLT3 and BET Inhibition in FLT3-ITD Acute Myeloid Leukemia

  2019cites this paper
• Blastic Plasmacytoid Dendritic Cell Neoplasm

  2018cites this paper
• The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders.

  2018cites this paper
• Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia.

  2018cites this paper
• Targeting DNA damage and repair mechanism in FLT3-ITD acute myeloid leukemia : a mechanistic and therapeutic study

  2018cites this paper
• Impact d’une infection par le virus grippal de type A sur la myélopoïèse

  2018cites this paper
• Navigating through Mutations in Acute Myeloid Leukemia. What Do We Know and What Do We Do with It?

  2018cites this paper
• Direct role of FLT3 in regulation of early lymphoid progenitors

  2018cites this paper
• Effect of Interval Training Intensity on Gene Expression of Endothelial Progenitor Cells and Cardiac Stem Cells in Aged Rats

  2018cites this paper
• Local Immunotherapies of Cancer

  2018cites this paper
• Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.

  2017cites this paper
• Multifactorial Immune Cell-Based Development of Heart Failure

  2017cites this paper
• Developmental and Functional Control of Natural Killer Cells by Cytokines

  2017cites this paper
• previous thrombosis will require stringent assessment, as D-dimer in these patients may be higher than in healthy individuals.

  2017cites this paper
• FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.

  2017cites this paper
• Flt 3 ligand-eGFP-reporter expression characterizes functionally distinct subpopulations of CD 150 + long-term repopulating murine hematopoietic stem cells

  2017cites this paper
• How I treat FLT3-mutated AML.

  2017cites this paper
• Human Hematopoietic Stem Cells: The Current Understanding and Future Prospects Pleurisy as a novel clinical manifestation associated with human herpesvirus 6 after unrelated cord blood transplantation Case report

  2017cites this paper
• Integration of hypoxic HIF-α signaling in blood cancers

  2017cites this paper
• Flt3 ligand‐eGFP‐reporter expression characterizes functionally distinct subpopulations of CD150+ long‐term repopulating murine hematopoietic stem cells

  2017cites this paper
• The spleen microenvironment influences disease transformation in a mouse model of KITD816V-dependent myeloproliferative neoplasm

  2017cites this paper
• Inhibition of FLT3 in AML: a focus on sorafenib

  2017cites this paper
• DOPAMINE RECEPTOR TARGETING IN HUMAN ACUTE MYELOID LEUKEMIA

  2017cites this paper
• Manufacture of red blood cells from stem cells

  2017cites this paper
• Small molecule mediated targeting of haematopoietic stem/progenitor cell and leukaemic stem cell function

  2017cites this paper
• FLT3/ITDAML and the law of unintended consequences

  2017cites this paper
• Human Hematopoietic Stem Cells: The Current Understanding and Future Prospects

  2017cites this paper
• MicroRNA regulation of macrophage activation

  2017cites this paper
• Roles of the Immune Cytokine Environment on Clonal Growth of Murine and Human Tet2 Mutant Bone Marrow Progenitors: Implications for Myelodysplastic Syndromes

  2017cites this paper
• Molecular Biology of Leukemias

  2017cites this paper
• Mammalian target of rapamycin (mTOR): a central regulator of male fertility?

  2017cites this paper
• FLT3–ITD and its current role in acute myeloid leukaemia

  2017cites this paper
• Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells

  2016cites this paper
• IMPACT OF LEISHMANIA DONOVANI INFECTION ON EARLY EVENTS IN HAEMATOPOIESIS

  2016cites this paper
• Editorial: Flt3 ligand—friend or foe?

  2016cites this paper
• Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells

  2016cites this paper
• On the origin of B cells. Elucidating the Role of Tyrosine Kinase Receptors in B Cell Development.

  2016influential citation
• Determinants of platelet count are different in patients with compensated and decompensated cirrhosis

  2016cites this paper
• The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues

  2016cites this paper
• The function of SH2B3 (LNK) in the kidney.

  2016cites this paper
• Receptor Tyrosine Kinases and Their Ligands

  2016cites this paper
• Characterization of Human CD8+TCR− Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγnull Mouse Model

  2016cites this paper
• Bioactive poly(ethylene glycol) hydrogels to recapitulate the HSC niche and facilitate HSC expansion in culture

  2016cites this paper
• Impaired signaling through the Fms‐like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis

  2016cites this paper
• Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations

  2016cites this paper
• Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

  2016cites this paper
• Significance of oncogenes and tumor suppressor genes in AML prognosis

  2016cites this paper
• Étude des gènes de fusion MLL dans les leucémies aigues humaines

  2016cites this paper
• Pharmacokinetic-pharmacodynamic analysis of sunitinib-induced thrombocytopenia in Japanese patients with renal cell carcinoma.

  2015cites this paper
• Flt3 in aml

  2015cites this paper
• Tyrosine kinase inhibitors modulate platelet function in vitro, ex vivo and in vivo

  2015cites this paper
• Receptor Tyrosine Kinases: Family and Subfamilies

  2015cites this paper